SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
about
T cell activationCeacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationCEACAM1: Expression and Role in Melanocyte TransformationCEACAM1 regulates TIM-3-mediated tolerance and exhaustionCarcinoembryonic antigen-related cell adhesion molecule-1 regulates granulopoiesis by inhibition of granulocyte colony-stimulating factor receptorHomophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-SrcCEACAM1 negatively regulates IL-1β production in LPS activated neutrophils by recruiting SHP-1 to a SYK-TLR4-CEACAM1 complexThe short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell inductionCEACAM6 gene variants in inflammatory bowel diseaseSHP-1 and SHP-2 in T cells: two phosphatases functioning at many levelsMoraxella catarrhalis adhesin UspA1-derived recombinant fragment rD-7 induces monocyte differentiation to CD14+CD206+ phenotypePerturbation of lytic and latent gammaherpesvirus infection in the absence of the inhibitory receptor CEACAM1Generation of human CEACAM1 transgenic mice and binding of Neisseria Opa protein to their neutrophils.Widespread divergence of the CEACAM/PSG genes in vertebrates and humans suggests sensitivity to selectionMechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesis.CEACAM1 induces B-cell survival and is essential for protective antiviral antibody productionMice with null mutation of Ceacam I develop nonalcoholic steatohepatitis.Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.Novel anti-melanoma immunotherapies: disarming tumor escape mechanisms.Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivoCarcinoembryonic Antigen Cell Adhesion Molecule 1 long isoform modulates malignancy of poorly differentiated colon cancer cells.Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms.Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.Negative signaling by inhibitory receptors: the NK cell paradigm.T cell Receptor Signal Transduction in T lymphocytes.Inside-out signaling promotes dynamic changes in the carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) oligomeric state to control its cell adhesion properties.Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease.Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner.CEACAM1 and the regulation of mucosal inflammation.Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant miceMolecular aspects of Moraxella catarrhalis pathogenesis.CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).Moraxella catarrhalis: from interactions with the host immune system to vaccine development.Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis.Roles of CEACAM1 in cell communication and signaling of lung cancer and other diseases.Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis.Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver DiseaseTumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.
P2860
Q24658051-64B242C8-03BC-4E75-BBD0-CC48697B90AAQ27334243-3AFA43B9-4C63-4A19-8CEC-74D882FB549AQ28072724-FFD8FCD2-C640-46B2-8C41-5536EE4A2974Q28115443-CBFCE0F6-93AC-43A7-B08E-A1010287115BQ28506530-63F7B778-79A0-44C9-B7B0-2B3521BD1B93Q28508235-E161016E-16A8-4627-B1FB-8E211C228D39Q28509313-F42814C5-4B61-4A1D-B19A-FDDADC409E79Q28592112-81F8665A-0DB8-45BD-B2FA-7E8D59D0796DQ28740558-F71A0637-7512-483F-8C68-CCCFD5D52711Q30436912-C5450F70-E1A4-48DB-8FCC-91455C5DE4B6Q31153140-267FDC26-8699-4DF0-BD95-D815B91E2D0AQ33484744-F70712B1-12F3-415E-98AE-3A35527717CFQ33559697-DAA7AEE3-764C-47AD-8B15-83B053EDE104Q34684871-B3B050AB-2F2F-4F4D-90C4-9CBFFC95B5FBQ34963359-107FDD08-CFD3-406B-978C-E5D4DAF87937Q35092790-B0B1F069-AE18-4AED-AA15-6DCE88B391FDQ35138138-8B0C1340-CB11-4AB6-A803-D828EAC5962DQ35226097-60A839A7-6800-4E59-B3AD-C90B37DB2E9AQ35487768-E97239A0-8E15-4C89-99F3-C5C9B596D237Q36067524-2DC83C39-1035-4D62-87C9-2B1088C10F6FQ36466018-3831C171-A13F-49CE-8E38-6BCFC4F7A0DAQ36782872-FED4DB28-8881-44E2-A962-A0D210FB79E4Q36798617-F7F45F3A-FD07-4C7E-A4C5-E683F3AE16E6Q36946554-0BB5133C-0DD0-4103-84EB-0925B177E5C7Q36983705-87C79B5D-A61B-4D24-90D9-E42E20EA026BQ37087575-9B73AE6F-67C0-4E32-A0E4-94BEEB6424CEQ37226181-41CBC855-1A94-44E8-A12F-B9CC0476778DQ37300999-9B96252C-EB5C-4CC5-8CDB-43FDCAAD6D79Q37304840-F628C311-1EB5-4F76-9B0F-B64BCBBA2268Q37349774-CB64BECB-16E8-4EDC-ABE6-64E7CC01329BQ37444112-CABA0AA8-98A1-49CF-B61F-72D160596268Q37590025-D0B99530-5C49-4732-AA36-CD0497507A47Q37624585-8AE57934-AC3F-4470-A5E6-88D50A8DC7F7Q38041190-A5CD65A3-0744-4A32-8564-7719645F6E9BQ38125604-F28696D8-ACAD-458D-B9B7-62DFBD156401Q38529754-C1DD071E-E79B-4AC3-B8D8-26C8D949DB96Q38636569-D8612722-A91D-490D-91D9-6BE2172DA3FAQ38970458-8A499980-9388-4B25-9B51-56B26A6C16F0Q39128964-B8E956DE-B7F3-43AF-8337-03860EDDC922Q39382030-ED157779-33F4-447F-A0C1-930949C5057D
P2860
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
description
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im November 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/11/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/11/01)
@nl
наукова стаття, опублікована в листопаді 2006
@uk
مقالة علمية (نشرت في نوفمبر 2006)
@ar
name
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
@ast
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
@en
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
@nl
type
label
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
@ast
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
@en
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
@nl
prefLabel
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
@ast
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
@en
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
@nl
P2093
P3181
P1433
P1476
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms
@en
P2093
Arthur Kaser
Atsushi Nakajima
Benjamin G Neel
Hideki Iijima
Jonathan Glickman
Richard S Blumberg
Sonia M Najjar
Sue-Hwa Lin
Takashi Nagaishi
P304
P3181
P356
10.1016/J.IMMUNI.2006.08.026
P407
P577
2006-11-02T00:00:00Z